British American Tobacco (NYSE: BTI) plans CAGNY talk, keeps 2026 guidance
Rhea-AI Filing Summary
British American Tobacco p.l.c. has furnished a Form 6-K to provide investors with a press release titled “BAT to Present at CAGNY; Reaffirming 2026 Full-Year Guidance” dated February 18, 2026. The filing mainly notifies the market of the upcoming CAGNY presentation and confirms that the company is maintaining its previously issued 2026 full-year outlook.
Positive
- None.
Negative
- None.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What is British American Tobacco (BTI) disclosing in this Form 6-K?
British American Tobacco is furnishing a Form 6-K that makes available a press release dated February 18, 2026. The release is titled “BAT to Present at CAGNY; Reaffirming 2026 Full-Year Guidance,” highlighting an upcoming investor presentation and confirmation of 2026 guidance.
What is the exhibit included in British American Tobacco’s (BTI) Form 6-K?
The Form 6-K includes one exhibit, a press release titled “British American Tobacco p. (the “Company” or “BAT”) - BAT to Present at CAGNY; Reaffirming 2026 Full-Year Guidance.” It is dated February 18, 2026 and provides the substantive information referenced in the filing.
Does British American Tobacco (BTI) reaffirm its 2026 full-year guidance in this filing?
Yes. The exhibit listed in the Form 6-K is a press release explicitly titled “BAT to Present at CAGNY; Reaffirming 2026 Full-Year Guidance.” This indicates the company is maintaining its previously communicated expectations for its 2026 full-year performance.
Who signed the British American Tobacco (BTI) Form 6-K filed on February 18, 2026?
The Form 6-K was signed on behalf of British American Tobacco p.l.c. by Christopher Worlock. He is identified in the document as the company’s Assistant Secretary, acting as the duly authorized signatory for this submission dated February 18, 2026.
Where is British American Tobacco’s (BTI) principal executive office located?
British American Tobacco p.l.c. lists its principal executive office as Globe House, 4 Temple Place, London WC2R 2PG, United Kingdom. This address is provided in the Form 6-K header as the company’s main registered office location for corporate and regulatory purposes.